Tryptophan and tyrosine availability and response to antidepressant treatment in major depression

J Affect Disord. 2005 Jun;86(2-3):129-34. doi: 10.1016/j.jad.2004.11.006.

Abstract

Background: It has been suggested that the ratio of tryptophan (TRP) and tyrosine (TYR) to other large neutral amino acids may predict response to antidepressant drugs with predominantly serotonergic compared with predominantly noradrenergic activity and that this may be clinically useful.

Method: 147 subjects with a DSM-III-R diagnosis of major depression underwent a detailed clinical evaluation and prior to treatment had baseline measures of TRP, TYR and other large neutral amino acids (LNAA), prolactin and cortisol. Subjects entered a 6-week randomised treatment trial comparing fluoxetine and nortriptyline.

Results: There was no main effect on 6-week outcome of TRP/LNAA ratio or TYR/LNAA ratio and no interaction between these factors and treatment (fluoxetine vs nortriptyline).

Limitations: Alterations in antidepressant dose were allowed therefore possibly reducing the effect of TRP or TYR availability on response.

Conclusions: Previous findings that TRP/LNAA and TYR/LNAA ratios may predict differential response to antidepressants were not replicated and neither was our previous finding of a complex relationship between TRP/LNAA and baseline prolactin in predicting 6-week response.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Uptake Inhibitors / pharmacology
  • Adrenergic Uptake Inhibitors / therapeutic use*
  • Adult
  • Amino Acids, Neutral / blood
  • Amino Acids, Neutral / drug effects
  • Antidepressive Agents, Tricyclic / pharmacology
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Circadian Rhythm
  • Depressive Disorder, Major / blood
  • Depressive Disorder, Major / drug therapy*
  • Female
  • Fluoxetine / pharmacology
  • Fluoxetine / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Hydrocortisone / blood
  • Hydrocortisone / metabolism
  • Male
  • Nortriptyline / pharmacology
  • Nortriptyline / therapeutic use*
  • Prolactin / blood
  • Psychiatric Status Rating Scales
  • Research Design
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Treatment Outcome
  • Tryptophan / blood*
  • Tryptophan / drug effects
  • Tyrosine / blood*
  • Tyrosine / drug effects
  • Tyrosine / metabolism

Substances

  • Adrenergic Uptake Inhibitors
  • Amino Acids, Neutral
  • Antidepressive Agents, Tricyclic
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Tyrosine
  • Tryptophan
  • Prolactin
  • Nortriptyline
  • Hydrocortisone